Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. - Wikidata - thesis-toulmin - TriplyDB

Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

http://www.wikidata.org/entity/Q34188389

about

Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery Mesoporous silica nanoparticles in target drug delivery system: A review Biosafe nanoscale pharmaceutical adjuvant materials Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer Theranostic Probes for Targeting Tumor Microenvironment: An Overview.Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Nanotechnology in diagnosis and treatment of coronary artery disease.Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells.Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response.Delivery of cancer therapeutics using nanotechnology Shedding light on nanomedicine.Integrated processing of contrast pulse sequencing ultrasound imaging for enhanced active contrast of hollow gas filled silica nanoshells and microshells.Hollow silica and silica-boron nano/microparticles for contrast-enhanced ultrasound to detect small tumors.One-step synthesis of degradable T(1)-FeOOH functionalized hollow mesoporous silica nanocomposites from mesoporous silica spheres.Safety assessments of subcutaneous doses of aragonite calcium carbonate nanocrystals in rats Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.Multifunctional hybrid materials for combined photo and chemotherapy of cancer.Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs.Synthesis and surface functionalization of silica nanoparticles for nanomedicine In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.Packaging biological cargoes in mesoporous materials: opportunities for drug delivery Measurement of Uptake and Release Capacities of Mesoporous Silica Nanoparticles Enabled by Nanovalve Gates.Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway.Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.In vivo enhancement of anticancer therapy using bare or chemotherapeutic drug-bearing nanodiamond particles.RNA-based TWIST1 inhibition via dendrimer complex to reduce breast cancer cell metastasis.Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer.Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.Alkaline and ultrasonic dissolution of biological materials for trace silicon determination.Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine.In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification.Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells.Organosilane and Polyethylene Glycol Functionalized Magnetic Mesoporous Silica Nanoparticles as Carriers for CpG Immunotherapy In Vitro and In Vivo Ligand-targeted theranostic nanomedicines against cancer Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.

P2860

Q26770108-0A487D9A-EEEA-42F9-B173-3C46599E4F3A Q26786070-0268D25F-7368-4843-B5F6-4B30DA19148E Q26799990-52E096B6-89FF-473E-8DAA-CF5256011911 Q26829798-C95E652B-5188-490A-BCB5-980C00D50D50 Q27021261-30A0C3AB-437D-434C-AFC3-4520735F3DF1 Q30354655-16130F08-93A3-46A7-A45C-BE135D44AC99 Q30361646-DB41A2EF-0CBD-4B43-9DE2-C212DDC91F8E Q30362371-A5A88051-B8BA-4E1A-9CCE-C9AC059944DE Q30434365-AA7C61A9-320B-48BE-8701-B9C83B5F35BA Q30445141-BEE661AF-E859-4893-9F06-1AEBBB0FD245 Q30446963-2D742D46-E421-45A4-B16D-507BC5EA7255 Q30447871-9B2FD30D-57FD-4920-B611-987A90B91FBE Q30455267-3DAA5E70-2F9F-429B-B06D-DD14AA52E8D7 Q30457622-E719A1D4-D7FD-47CB-9802-5284732576C7 Q30884179-F2E9C165-47F4-44D3-8C2F-C5A31E14CBA0 Q33665671-99181600-F4E6-47DC-9566-6795A9FCBE3A Q33993918-0AD585B6-8A14-4376-938C-C33FF4B5E4BD Q34255469-3D2D44FC-F9D3-4223-81ED-D3931B2FCEE6 Q34314945-CE88B91F-548C-4405-AA51-FFF7CDF1CA82 Q34417407-32638F4A-B452-4CF8-BB6B-D4DBEBABDBAA Q34446399-E2B8A34A-7755-4DCF-A39B-752ADC738887 Q34576316-928AF3BB-03BC-4B1F-81B8-C9B7C583359E Q34718595-6AA64DE4-B766-4F17-94D4-3149EF494175 Q34763969-5841ECDD-75AC-4608-A5D5-95D7EF167069 Q35091821-78864947-D885-44BA-9316-C68B2B3C6D3C Q35109951-7BBD673C-72FF-4EAF-9DD3-22C3A0919E36 Q35119155-9C86AD72-0699-4E44-8AFA-5B25B6B11021 Q35144398-116F7106-B324-438C-99B4-152C8A1EE4B3 Q35162222-9193B082-44E1-43BD-B44E-8833C59EC018 Q35265473-1BD23AC6-BC2A-47EF-AE22-5AE167FA0CF8 Q35387777-10E2EF68-5E53-410B-85A4-C3D0CF729D8D Q35566413-64815012-4D1A-4482-952A-E43524049D8C Q35797575-E569E4D6-DA11-4361-8766-352D473B8C29 Q35801557-F0D67976-8927-4D63-AFD4-381898DC34A2 Q35895637-73A0D459-7359-4CE4-BA6E-AF81252441D4 Q35921552-BFB44D05-16FC-4082-8E71-6DDB78957C5C Q35941391-CFE933D4-E181-41B1-93D9-7B026C7B7F18 Q35955366-D03F1709-2270-45E3-8604-5040FD4D982C Q35978871-61FAEBBC-A7E7-4E28-80B2-4601D2DF32A7 Q35984023-B20C9132-CF25-4A92-81A1-59C749D00D03

P2860

Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

http://www.wikidata.org/entity/Q34188389

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@ast

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@en

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@nl

type

label

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@ast

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@en

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@nl

prefLabel

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@ast

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@en

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@nl

P1433

Q34188389-705F37B6-FD0E-4B0B-AC7B-9484B630E3BC

P1476

Q34188389-A3940D60-B039-4A62-A2F2-3C401714FE8D

P2093

Q34188389-225C77E9-00C1-4212-9864-F0B57E4BAB5A

Q34188389-26F1A76A-513B-40F4-8462-A558504D10AB

Q34188389-73A4B55E-369B-4B2D-A7C1-B35EB8AD1B34

Q34188389-D968EEBE-49CA-42E6-BCD3-115607150646

Q34188389-E97E4668-F36A-46C7-BA33-F4767005E496

P2860

Q34188389-06EC85ED-F36D-4D68-8AF4-FDDA641839E4

Q34188389-09D0D7FA-8348-4F16-B03B-25B80FB0453A

Q34188389-0A8A5849-8FCC-4635-9EF0-4DC5754D62F9

Q34188389-0CA4D839-0877-4676-9B53-F00E7C52B0E6

Q34188389-0D6A70AA-504F-474B-BA22-39C4D8A19934

Q34188389-103C0E36-C73D-4BE2-9D53-C07E3C96DF7B

Q34188389-24F49424-EF0A-44D1-8D88-BEE8AB09DCED

Q34188389-30BDD74C-460E-442F-80FB-1D659BDE6584

Q34188389-328BD928-65FE-49BC-AEE3-799F0063DBD8

Q34188389-3A92B814-ED33-4D52-A35C-D890B7BA1D79

P304

Q34188389-D4DDB553-546E-4E36-8C83-AB5336A96A61

P31

Q34188389-54770DFE-A1F8-4A9C-A046-16318CC86545

P356

Q34188389-AFD2A71D-23E2-4D04-AE6F-88036663DAE6

P433

Q34188389-93B086CB-ACCF-4F76-9606-5B93FCA5D061

P478

Q34188389-A4FF9A39-530E-4A87-BC2E-20ED83EE826E

P577

Q34188389-C04C33B9-D465-42DA-B0F9-A81D35822741

P5875

Q34188389-D506DF4A-C3B4-4305-A607-BA3A54366916

P698

Q34188389-B77356DC-A2F8-466C-9B81-FC0FE264F3D8

P921

Q34188389-19EC89F6-B237-4210-8242-ED25CAB10B86

Q34188389-710573AC-CA22-4042-BC83-CF611780CE2A

P932

Q34188389-6E9AF3FA-1579-4F86-8EE2-B876623EB0F8

P356

P1433

P1476

Biocompatibility, biodistribut ...... for cancer therapy in animals.

@en

P2093

Fuyuhiko Tamanoi

http://www.w3.org/2001/XMLSchema#string

Jeffrey I Zink

http://www.w3.org/2001/XMLSchema#string

Jie Lu

http://www.w3.org/2001/XMLSchema#string

Monty Liong

http://www.w3.org/2001/XMLSchema#string

Zongxi Li

http://www.w3.org/2001/XMLSchema#string

P2860

Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent

Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells.

Controlled synthesis, characterization, and catalytic properties of Mn(2)O(3) and Mn(3)O(4) nanoparticles supported on mesoporous silica SBA-15.

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery.

pH-responsive mechanised nanoparticles gated by semirotaxanes.

Silica nanoparticles as a delivery system for nucleic acid-based reagents.

Nanoparticle-based targeted drug delivery

Luminescent silica nanobeads: characterization and evaluation as efficient cytoplasmatic transporters for T-lymphocytes.

P304

1794-1805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SMLL.201000538

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45152490

http://www.w3.org/2001/XMLSchema#string

P698

20623530

http://www.w3.org/2001/XMLSchema#string

P921

P932

2952648

http://www.w3.org/2001/XMLSchema#string